Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Keating

Showing results (391-400 of 436) with videos related to

Pageof 44
Sort By:
Leukemia|March 31, 2012
Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemiaM Sivina, E Hartmann, E Vasyutina, et al.
Leukemia & Lymphoma|December 29, 1999
Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II studyF J Giles, S M O'Brien, V Santini, et al.
Cancer|April 15, 1980
Factors related to length of complete remission in adult acute leukemiaM J Keating, T L Smith, E A Gehan, et al.
Blood|July 1, 1995
p16INK4A and p15INK4B gene deletions in primary leukemiasM A Haidar, X B Cao, T Manshouri, et al.
Leukemia|September 24, 2004
Hairy cell leukemia with large cells: long disease course with adequate response to therapyX Sun, H M Amin, E J Freireich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemiaM J Keating, E A Gehan, T L Smith, et al.
Cancer|August 15, 1988
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemiaR S Walters, H M Kantarjian, M J Keating, et al.
Cancer|December 14, 1999
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patientsS Sacchi, H M Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical responseV Gandhi, W Plunkett, C O Rodriguez, et al.
Cancer Treatment Reports|June 1, 1979
Phase I-II study of piperazinedione in adults with solid tumors and acute leukemiaR S Benjamin, M J Keating, M Valdivieso, et al.
Pageof 44

Showing results (391-400 of 436) with videos related to

Sort By:
Pageof 44
Leukemia|March 31, 2012
Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemiaM Sivina, E Hartmann, E Vasyutina, et al.
Leukemia & Lymphoma|December 29, 1999
Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II studyF J Giles, S M O'Brien, V Santini, et al.
Cancer|April 15, 1980
Factors related to length of complete remission in adult acute leukemiaM J Keating, T L Smith, E A Gehan, et al.
Blood|July 1, 1995
p16INK4A and p15INK4B gene deletions in primary leukemiasM A Haidar, X B Cao, T Manshouri, et al.
Leukemia|September 24, 2004
Hairy cell leukemia with large cells: long disease course with adequate response to therapyX Sun, H M Amin, E J Freireich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemiaM J Keating, E A Gehan, T L Smith, et al.
Cancer|August 15, 1988
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemiaR S Walters, H M Kantarjian, M J Keating, et al.
Cancer|December 14, 1999
Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patientsS Sacchi, H M Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical responseV Gandhi, W Plunkett, C O Rodriguez, et al.
Cancer Treatment Reports|June 1, 1979
Phase I-II study of piperazinedione in adults with solid tumors and acute leukemiaR S Benjamin, M J Keating, M Valdivieso, et al.
Pageof 44